Skip to main content

Eating Disorders in Adolescence

0
Pipeline Programs
3
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
3 programs
The Body ProjectN/A1 trial
mind. body. voiceN/A1 trial
mind. body. voice.N/A1 trial
Active Trials
NCT04263155Completed74Est. Mar 2020
NCT04591912Completed170Est. May 2022
NCT04591886Completed120Est. May 2021
Innovation Pharmaceuticals
1 program
GGTCA-AD mobile appN/A1 trial
Active Trials
NCT06039514Completed93Est. May 2024
NewBridge Pharmaceuticals
1 program
Newbridge Eating disorders Activity Treatment groupN/A1 trial
Active Trials
NCT04552639Unknown80Est. Dec 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Innovation PharmaceuticalsGGTCA-AD mobile app
Colorado Therapeuticsmind. body. voice
NewBridge PharmaceuticalsNewbridge Eating disorders Activity Treatment group
Colorado Therapeuticsmind. body. voice.
Colorado TherapeuticsThe Body Project

Clinical Trials (5)

Total enrollment: 537 patients across 5 trials

Mobile App for Eating Disorders in Adolescents

Start: Apr 2024Est. completion: May 202493 patients
N/ACompleted

The Peer-Delivered "Mind. Body. Voice." Program for High School Women (Mbv) - Remote

Start: Oct 2020Est. completion: May 2022170 patients
N/ACompleted
NCT04552639NewBridge PharmaceuticalsNewbridge Eating disorders Activity Treatment group

Evaluation of Compulsive Exercise Group Therapy for Eating Disorders

Start: Oct 2020Est. completion: Dec 202280 patients
N/AUnknown

The Peer-Delivered "Mind. Body. Voice." Program for High School Women

Start: Sep 2019Est. completion: May 2021120 patients
N/ACompleted

The Peer-Delivered Body Project for Young Women in High School

Start: Aug 2018Est. completion: Mar 202074 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.